Robert Ventzki and Josef Stegemann have been working together at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, for more than 15 years in the field of biophysical instrumentation. Robert Ventzki studied physics and human physiology in Heidelberg and at San Diego State University (SDSU), USA, as a Fulbright Scholar, and obtained his PhD in natural sciences from the University of Heidelberg in 1999. Josef Stegemann graduated in physics at the Westphalian Wilhelms University Münster, Germany, in 1982.
With a specialisation in optics, lasers and photodetection, they contributed significantly to the development of the ARAKIS and the ALF DNA sequencer, which was commercialized by Amersham Pharmacia (now GE Healthcare). They have many publications and patent applications in the field of microanalytical techniques. Their current research is focused on methods and technological developments for functional genomics and proteomics. Their most recent development is a system for protein analysis, based on 3D-gel electrophoresis with online detection of laser-induced fluorescence (LIF). After a 3 years' stay at the Institute for Microbiology, University of Greifswald, Robert Ventzki is now pursuing his research at the Institute for Neuro- & Sensory Physiology, University Medical Center Göttingen, Germany.
Prof. Dr. Michael Hecker, Dr. Jörg Bernhardt, Institute for Microbiology, University of Greifswald, Germany
Prof. Dr. Fred Wouters, Dr. Gertrude Bunt, Institute for Neuro- & Sensory Physiology, University Medical Center Göttingen, Germany
Prof. Dr. mult. Thomas Meyer, Laboratory for Molecular Psycho-Cardiology, University Medical Center Göttingen, Germany